Ronald J. Kulich, PhDLecture
This course is part of the Association for Continuing Dental Education Joint Live Webinar Series.
This course is part of the Association for Continuing Dental Education Joint Live Webinar Series*
Current data is presented with respect to the presence of controlled substance use among general practice patients, cost effective strategies for conducting a valid assessment, and crisis strategies for management, tapering, and interprofessional collaboration
At the conclusion of this course, participants will be able to:
- Discuss current research findings associated with controlled substance risk assessment, particularly as they relate to opioid therapy
- Recognize particularly at-risk sub-groups, including populations utilizing controlled substances
- Review tools and techniques for assessing and managing the patient at risk
Dr. Ronald Kulich has responsibilities including development and management of opioid risk assessment protocols for the Massachusetts General Hospital Pain Center and Facial Pain/Headache Center at Tufts School of Dental Medicine. Other academic responsibilities include treatment guideline development for work injury with specific focus on opioid therapy risk, Massachusetts Department of Industrial Accidents, membership in the Mass Pain Initiative Public Policy Council, and training committee for the MA Prescription Monitoring Program. Much of his recent work has been focused on CME/CE content development with respect to risk assessment for controlled substances. He has co-chaired the Massachusetts Dental Education Core Competencies Subcommittee for the Prevention and Management of Prescription Drug Misuse, and maintains membership in the Law Enforcement Prescription Monitoring Program Educational Program. His fellowship training responsibilities include supervision of Anesthesia/Pain Medicine and Orofacial Pain Medicine Fellows (Mass General Hospital), management of the behavioral sciences curriculum for Tufts School of Dental Medicine, and supervision of psychology graduate interns within the pain centers. Patient clinical care and assessment activities include evidence-based use of screening/assessment with a range of chronic pain populations, and impact of public policy on access to pain care. His work has resulted in over 100 publications. Most recent publications focus on questionnaire construction, and outcome predictors with chronic opioid therapy.
Wednesday, March 22, 2023
The dental professional
5:00pm – 6:00pm Pacific Standard time
*The University of Washington in conjunction with the Association for Continuing Dental Education (ACDE), along with 30 of its member schools jointly presents the “ACDE Webinar Series”
This series features university-based key opinion leaders presenting numerous topics on multiple dates and times. Presentations are available to meet every dental health care professional’s schedule and interests.
The University of Washington is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between the University of Washington and Oregon Health Sciences University.
The University of Washington is a member of the Association for Continuing Dental Education.
University of Washington designates this activity for 1 continuing education credit.